{"certainAgreement":{"otherDetails":"Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Due to character limitation in outcome measure(OM)description, expanded form for ICANS, ASTCT, ICE is provided here. Immune Effector Cell-Associated Neurotoxicity, American Society for Transplantation and Cellular Therapy, Immune Effector Cell-Associated Encephalopathy respectively."},"pointOfContact":{"email":"ClinicalTrials.gov_Inquiries@pfizer.com","organization":"Pfizer Inc.","phone":"1-800-718-1021","title":"Pfizer ClinicalTrials.gov Call Center"}}